ProCE Banner Activity


Sending Out an SOS for EoE: Raising Awareness Around Diagnosis, Treatment, and Transition of Care


In this eCourse, an expert faculty provides steps for appropriate diagnosis of eosinophilic esophagitis (EoE) and discusses guideline-directed and newly approved therapies to treat EoE as well as considerations for effective transition of care from pediatric to adult-centered care.

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurse Practitioners: 1.00 Nursing contact hours, includes 1.00 hour of pharmacotherapy credit

Released: February 17, 2023

Expiration: February 16, 2024

No longer available for credit.



Ikuo Hirano

Ikuo Hirano, MD

Professor of Medicine
Division of Gastroenterology and Hepatology
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Gwen Cassidy

Gwen Cassidy, APN

Nurse Practitioner
Digestive Health Center
Northwestern Medicine
Chicago, Illinois

Provided by

ProCE Banner


This activity is supported by educational grants from

Regeneron Pharmaceuticals, Inc


Target Audience

Gastroenterology, allergy, and primary care NPs and PAs who care for patients with eosinophilic esophagitis.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe key elements of EoE pathophysiology

  • Identify patients with EoE early in the course of disease using evidence-based guidelines and diagnostic criteria

  • Evaluate current and emerging treatments based on their impact on disease outcomes in patients with EoE

  • Integrate strategies to effectively transition adolescent and young adult patients with EoE from pediatric to adult care


All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Gwen Cassidy, APN: consultant/advisor/speaker: Sanofi Regeneron, Phathom.

Ikuo Hirano, MD: consultant/advisor/speaker: Allakos, Arena, AstraZeneca, Ellodi/Adare, EsoCap Biotech, Gossamer Bio, Lilly, Meritage, Phathom, Receptos/Celgene, Sanofi/Regeneron, Shire; researcher: Allakos, Ellodi/Adare, Meritage, Receptos/Celgene, Regeneron, Shire.

The planners and content peer reviewers from Partners for Advancing Clinical Education and Practicing Clinicians Exchange do not have any relevant financial relationships to disclose.

Instructions for Credit

Learners wishing to earn CE/CME credit must: 

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete evaluation form 

The estimated time to complete this activity is 1.00 hour.


This program has been made available online.


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Partners for Advancing Clinical Education, Practicing Clinicians Exchange, or any educational supporter.


Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit.


AAPA Credit Designation
Joint AccreditationPartners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until February 16, 2024. PAs should only claim credit commensurate with the extent of their participation.


IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.